🔎 Trials Near Me

Hjem › Seglcelle-anæmi › Illinois › Chicago

Seglcelle-anæmi kliniske forsøg i Chicago, IL

18 studier for Seglcelle-anæmi søger deltagere på steder i og omkring Chicago (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease

RekruttererFase 1
  • University of Illinois at Chicago College of Medicine, Chicago
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT04055818

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

RekruttererFase 1
  • University of Illinois Hospital and Health Sciences System, Chicago
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07187973

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

RekruttererFase 3
  • Univer Of Illinois at Chicago, Chicago
Alder 2 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

RekruttererFase 3
  • Childrens Hospital of Chicago, Chicago
  • Univer Of Illinois at Chicago, Chicago
Alder 12 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT06612268

Tocilizumab for Acute Chest Syndrome

RekruttererFase 2
  • University of Chicago, Chicago
Alder 12 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT05640271

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
  • Local Institution - 0034, Chicago
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT06481306

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

RekruttererFase 2/3
  • University of Illinois at Chicago Clinical Research Center, Chicago
  • University of Illinois Hospital and Health Sciences System - Investigational Drug Services (IDS), Chicago
  • University of Illinois Hospital and Health Sciences System, Chicago
Alder 12 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT05431088

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

RekruttererObservationsstudie
  • Rush University Medical Center, Chicago
Alle aldre · Alle køn · Opdateret 17. aug. 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

RekruttererFase 2
  • University of Illinois at Chicago, Chicago
Alder 12 og opefter · Alle køn · Opdateret 14. aug. 2026 · NCT06699849

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

RekruttererFase 3
  • University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago
Alder 10 til 65 · Alle køn · Opdateret 29. jul. 2026 · NCT06975865

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

RekruttererFase 2
  • University of Illinois at Chicago, Chicago
Alder 16 til 60 · Alle køn · Opdateret 8. jul. 2026 · NCT03121001

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

RekruttererObservationsstudie
  • Comer Children's Hospital (MRD-HCT), Chicago
Alder 3 til 20 · Alle køn · Opdateret 4. jun. 2026 · NCT06941389

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

RekruttererFase 2
  • University of Illinois Chicago, Sickle Cell Center, Chicago
Alder 18 til 60 · Alle køn · Opdateret 19. maj 2026 · NCT07175051

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

Rekrutterer
  • University of Illinois at Chicago, Chicago
Alder 18 og opefter · Alle køn · Opdateret 23. mar. 2026 · NCT06919224

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

RekruttererFase 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Alder 2 til 25 · Alle køn · Opdateret 10. mar. 2026 · NCT03587272

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

Rekrutterer
  • Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Alder 16 til 30 · Alle køn · Opdateret 7. jan. 2026 · NCT06374238

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

RekruttererObservationsstudie
  • University of Illinois, Chicago
Alder 18 og opefter · Alle køn · Opdateret 22. jun. 2025 · NCT06385886

Seglcelle-anæmi forsøg i andre byer

Andre studier i Chicago

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.